Palisade Bio (PALI) Shares Outstanding (Diluted Average) (2016 - 2026)

Palisade Bio (PALI) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $209.7 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $209.7 million, up 4271.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $209.7 million (up 4271.97% YoY), and the FY2025 annual result was $55.7 million, up 3830.18% from the prior year.
• Shares Outstanding (Diluted Average) rose to $209.7 million in Q1 2026 per PALI's latest filing, from $55.7 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $209.7 million in Q1 2026 and troughed at $287702.0 in Q1 2023.
• A 5-year average of $17.0 million and a median of $974197.0 in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Diluted Average) slumped 91.95% in 2022, then soared 4271.97% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $880311.0 in 2022, then tumbled by 48.2% to $456014.0 in 2023, then soared by 210.62% to $1.4 million in 2024, then soared by 3830.18% to $55.7 million in 2025, then soared by 276.62% to $209.7 million in 2026.
• Business Quant data shows PALI's Shares Outstanding (Diluted Average) at $209.7 million in Q1 2026, $55.7 million in Q4 2025, and $5.7 million in Q3 2025.